Patient experiences using Evra [Estradiol/progestogen] for management of menstrual related symptoms

Trial Profile

Patient experiences using Evra [Estradiol/progestogen] for management of menstrual related symptoms

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2013

At a glance

  • Drugs Estradiol/progestogen (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 02 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top